Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Musculoskeletal
Disease Category: Acromegaly

Trial Information

Acromegaly Study CSOM230C2305

Novartis is conducting this clinical research study is to determine the most safe and effective dose of an investigational drug for participants who are between 18 and 80 years old and have active acromegaly. An "investigational drug" is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA).

Participants will be asked to visit the study center 18 times over 12 months to receive treatment once a month.
For more information about this clinical trial, visit www.NovartisClinicalTrials.com

Research Center
Located In:
Various Cities, TX

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.